No Data
No Data
[Hong Kong Stock Connect] Wuxi Bio (02269) rose by 8.14% as the earlier version of the US Biosafety Law was partially amended. Wuxi Bio was not included.
Kingwus Financial News | Wuxi Biologics (02269) oscillated stronger, as of press time, up 8.14%, at HK$17.28, with a turnover of 2.102 billion Hong Kong dollars. On the news front, on September 23, local time in the USA, Chairman of the Senate Committee on Homeland Security and Governmental Affairs, Gary Peters, submitted an amendment S.3558 to the Senate. The S.3558 bill, previously widely known as the Senate version of the 'Biological Safety Act,' had 11 votes in favor and 1 vote against at a hearing held by the Senate Committee on Homeland Security and Governmental Affairs in March this year.
Trending Industry Today: SUNAC Leads Gains In Top Gainers Yesterday Stocks
Trending Industry Today: WUXI BIO Leads Gains In Biotechnology Stocks
Trending Industry Today: WUXI APPTEC Leads Gains In Biotechnology Stocks
Trending Industry Today: WUXI BIO Leads Gains In CRO Stocks
HK stocks anomaly | CRO concept stocks continue to rise, hindered by the enactment of the Biosecurity Law, top companies' investment sentiment is expected to marginally improve.
The CRO concept stocks continue to rise. As of the time of publication, Tigermed (03347) rose by 9.28%, to 31.2 Hong Kong dollars; Pharmaron (03759) rose by 4.85%, to 11.24 Hong Kong dollars; and Joinn Laboratories (06127) rose by 4.8%, to 7.64 Hong Kong dollars.
No Data
No Data